Jump to navigation Jump to search
Fab fragment of sifalimumab bound to IFN-α2A. From .
|Chemical and physical data|
|Molar mass||146.25 kg/mol g·mol−1|
|(what is this?)|
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Sifalimumab" (PDF). American Medical Association.
- "Press release: New Hope for Lupus Patients". MedImmune. 11 August 2015. Archived from the original on 31 July 2017.
- "Sifalimumab". AdisInsight. Retrieved 31 July 2017.
- "Sifalimumab". NHS Specialist Pharmacy Service. Retrieved 31 July 2017.
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|